CD
IBB icon

Chapin Davis’s iShares Biotechnology ETF IBB Stock Holding History

Chapin Davis’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$395K Hold
2,077
– – 0.07% 167
2026
Q1 		$351K Hold
2,077
– – 0.08% 187
2025
Q4 		$351K Hold
2,077
– – 0.08% 176
2025
Q3 		$300K Sell
2,077
-70
-3% -$9.55K 0.07% 194
2025
Q2 		$272K Hold
2,147
– – 0.08% 185
2025
Q1 		$275K Sell
2,147
-118
-5% -$16K 0.09% 171
2024
Q4 		$330K Hold
2,265
– – 0.11% 163
2024
Q3 		$330K Buy
2,265
+340
+18% +$49.2K 0.11% 164
2024
Q2 		$264K Buy
1,925
+360
+23% +$48.1K 0.09% 181
2024
Q1 		$215K Buy
+1,565
New +$214K 0.08% 204

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Chapin Davis's IBB Position: Q2 2026 in Review

Chapin Davis held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 2,077 shares worth $395K. The position accounts for 0.07% of the portfolio, ranked #167.

Chapin Davis first reported a position in IBB in Q1 2024 and has held it in 10 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Chapin Davis held 2,077 shares of iShares Biotechnology ETF worth $395K as of Q2 2026.
  • Chapin Davis left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.07% of Chapin Davis's portfolio in Q2 2026, its #167 holding.
  • Chapin Davis first reported a position in iShares Biotechnology ETF in Q1 2024 and has held it in 10 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Chapin Davis's 13F filing for Q2 2026, filed 7 Jul 2026.